<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A gene signature specific for intestinal stem cells (ISCs) has recently been shown to predict relapse in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) but the tumorigenic role of individual signature genes remains poorly defined </plain></SENT>
<SENT sid="1" pm="."><plain>A prominent ISC-signature gene is the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell marker CD44, which encodes various splice variants comprising a diverse repertoire of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and signaling molecules </plain></SENT>
<SENT sid="2" pm="."><plain>Using Lgr5 as ISC marker, we have fluorescence-activated cell sorting-purified ISCs to define their CD44 repertoire </plain></SENT>
<SENT sid="3" pm="."><plain>ISCs display a specific set of CD44 variant isoforms (CD44v), but remarkably lack the CD44 standard (CD44s) isoform </plain></SENT>
<SENT sid="4" pm="."><plain>These CD44v also stand-out in transformed human ISCs isolated from microadenomas of <z:e sem="disease" ids="C0032580" disease_type="Neoplastic Process" abbrv="">familial adenomatous polyposis</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>By employing knock-in mice expressing either CD44v4-10 or CD44s, we demonstrate that the CD44v isoform, but not CD44s, promotes <z:mpath ids='MPATH_270'>adenoma</z:mpath> initiation in Apc(Min/+)mice </plain></SENT>
<SENT sid="6" pm="."><plain>Our data identify CD44v as component of the ISCs program critical for <z:e sem="disease" ids="C0598935" disease_type="Neoplastic Process" abbrv="">tumor initiation</z:e>, and as potential treatment target in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>.Oncogene advance online publication, 14 January 2013; doi:10.1038/onc.2012.611 </plain></SENT>
</text></document>